LV10953A - Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija - Google Patents

Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija

Info

Publication number
LV10953A
LV10953A LV931045A LV931045A LV10953A LV 10953 A LV10953 A LV 10953A LV 931045 A LV931045 A LV 931045A LV 931045 A LV931045 A LV 931045A LV 10953 A LV10953 A LV 10953A
Authority
LV
Latvia
Prior art keywords
manufacture
pharmaceutical composition
substituted benzimidazoles
benzimidazoles
substituted
Prior art date
Application number
LV931045A
Other languages
English (en)
Inventor
Arne Elof Braandstroom
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10953A publication Critical patent/LV10953A/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
LV931045A 1990-06-20 1993-08-27 Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija LV10953A (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds
PCT/SE1991/000415 WO1991019711A1 (en) 1990-06-20 1991-06-11 Substituted benzimidazoles, process for their preparation and their pharmaceutical use

Publications (1)

Publication Number Publication Date
LV10953A true LV10953A (lv) 1995-12-20

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
LV931045A LV10953A (lv) 1990-06-20 1993-08-27 Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija

Country Status (27)

Country Link
EP (1) EP0535081A1 (lv)
JP (1) JPH05507713A (lv)
CN (1) CN1058212A (lv)
AP (1) AP215A (lv)
AU (1) AU649453B2 (lv)
BG (1) BG97200A (lv)
CA (1) CA2083714A1 (lv)
CZ (1) CZ279772B6 (lv)
FI (1) FI925766A (lv)
HU (1) HUT62881A (lv)
IE (1) IE912025A1 (lv)
IL (1) IL98470A0 (lv)
IS (1) IS3721A7 (lv)
LT (2) LT3952B (lv)
LV (1) LV10953A (lv)
MA (1) MA22199A1 (lv)
NO (1) NO924775L (lv)
NZ (1) NZ238546A (lv)
OA (1) OA09682A (lv)
PT (1) PT98035A (lv)
RO (1) RO110493B1 (lv)
SE (1) SE9002206D0 (lv)
TN (1) TNSN91049A1 (lv)
TW (1) TW216418B (lv)
WO (1) WO1991019711A1 (lv)
YU (1) YU104191A (lv)
ZA (2) ZA914296B (lv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
ATE281164T1 (de) 2000-02-24 2004-11-15 Kopran Res Lab Ltd Oral verabreichbare säurebeständige geschwürbehandelnde benzimidazolderivate
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
DE60325709D1 (de) 2002-04-09 2009-02-26 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
PL2046334T3 (pl) 2006-07-25 2015-02-27 Vecta Ltd Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
US20110009624A9 (en) * 2006-10-13 2011-01-13 Masato Ueda Benzimidazole compounds having gastric acid secretion inhibitory action
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
WO2010151216A1 (en) 2009-06-25 2010-12-29 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
EP2519229A2 (en) 2009-12-29 2012-11-07 Novartis AG New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
CA2860231A1 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
MX2019002726A (es) * 2016-09-14 2019-09-23 Jane Tseng Yufeng Novedosos derivados sustituidos como inhibidores de la d-aminoacido oxidasa (daao).

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (lv) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
WO1989003830A1 (en) * 1987-10-30 1989-05-05 Aktiebolaget Hässle 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss
EP0390842A1 (de) * 1987-12-11 1990-10-10 Byk Gulden Lomberg Chemische Fabrik GmbH Neue benzimidazolderivate
EP0415990A1 (de) * 1988-05-25 1991-03-13 Byk Gulden Lomberg Chemische Fabrik GmbH Neue fluoralkoxyverbindungen

Also Published As

Publication number Publication date
LTIP1712A (en) 1995-08-25
IS3721A7 (is) 1991-12-21
CZ279772B6 (cs) 1995-06-14
LTIP1713A (en) 1995-08-25
HU9204033D0 (en) 1993-03-29
TW216418B (lv) 1993-11-21
MA22199A1 (fr) 1992-04-01
FI925766A0 (fi) 1992-12-18
JPH05507713A (ja) 1993-11-04
IE912025A1 (en) 1992-01-01
NO924775D0 (no) 1992-12-10
SE9002206D0 (sv) 1990-06-20
CA2083714A1 (en) 1991-12-21
YU104191A (sh) 1994-01-20
AU649453B2 (en) 1994-05-26
AP9100285A0 (en) 1991-07-31
CN1058212A (zh) 1992-01-29
NO924775L (no) 1992-12-10
ZA914297B (en) 1992-03-25
AP215A (en) 1992-09-02
OA09682A (en) 1993-05-15
CS189491A3 (en) 1992-04-15
HUT62881A (en) 1993-06-28
WO1991019711A1 (en) 1991-12-26
TNSN91049A1 (fr) 1992-10-25
LT3977B (en) 1996-06-25
NZ238546A (en) 1994-03-25
LT3952B (en) 1996-05-27
AU8009791A (en) 1992-01-07
IL98470A0 (en) 1992-07-15
RO110493B1 (ro) 1996-01-30
BG97200A (bg) 1993-12-24
PT98035A (pt) 1992-03-31
FI925766A (fi) 1992-12-18
ZA914296B (en) 1992-03-25
EP0535081A1 (en) 1993-04-07

Similar Documents

Publication Publication Date Title
LV10953A (lv) Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE10199066I1 (de) Pharmazeutische Zusammensetzung
LV10082A (lv) Propenskabes atvasinajumi to iegusanas panemiens sastavs un pielietosana senisu kukainu un ercu apkarosanai
FI981777A0 (fi) Farmaseuttinen ainekoostumus
SE8801813L (sv) Pharmaceutical composition
DE4391813T1 (de) Zusammensetzung aus plastifiziertem Gips
DE3486441D1 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
ITRM910061A0 (it) Composizioni di calcestruzzo da spruzzare
FR2636532B1 (fr) Compositions pharmaceutiques
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
BR8902337A (pt) Composicao oral
BG91785A (bg) Лекарствена форма
BR8902338A (pt) Composicao oral
MX158797A (es) Mejoras a composicion limpiadora y desodorante para el cuerpo
DK683987D0 (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
MX9200622A (es) Composicion farmaceutica
BR8903994A (pt) Composicao oral
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
UA26064A1 (uk) Фармацевтичhа композиція
LV12067A (lv) 17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai
DK0511991T3 (da) Farmaceutisk formulering
ATA133288A (de) Pharmazeutische zusammensetzung
IT8721981A0 (it) Composizione farmaceutica antiinfiammatoria ad effetto prolungato ad uso topico
IT9020943A0 (it) Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei